Everything you need on shift
Strain-level dossiers
One-page summary of strain identity, mechanism, dose, studies, contraindications and shelf life — written for clinicians.
Patient handouts
Plain-language take-home sheets, translated, that explain dosing, what to expect and when to come back. Printable or QR-shareable.
Sample programme
Request starter packs for chairside trials. Free for first orders, dispatched within 48 hours within the EU.
Medical hotline
A medical-affairs lead on Slack and email for off-label questions, interactions and case discussion. Reply within one working day.
Microbiome testing
Optional partner stool-test integration so you can pair the right Medalta product with the right baseline microbiome profile.
Professional pricing
Verified practitioners receive a permanent professional discount and access to clinic-only multi-pack SKUs.
Built on evidence, used in clinic.
120+
Characterised bacterial strains in our reference library
9
Clinical or pre-clinical studies in active programmes
3.2M
Daily doses produced under GMP per year
14
International markets where Medalta is distributed
We are more than a science - we are a way of life
Each line addresses a different need
— but every formula traces back to the same library of characterised strains.
History
Our flagship anti-inflammatory programme. Postbiotic-derived, omega-stabilised, mechanism-led.
Medalta Lab
Our flagship anti-inflammatory programme. Postbiotic-derived, omega-stabilised, mechanism-led.
Bacteria-First
Our flagship anti-inflammatory programme. Postbiotic-derived, omega-stabilised, mechanism-led.
From strain to
clinical effect.
Three steps explain why Medalta formulations are different from a typical retail probiotic: every product traces back to characterised
strains, dose-justified actives and measurable host-level endpoints.
Characterised strain
Each strain identified to whole-genome level, deposited in a public collection and traceable to a master cell bank.
Dose-justified active
CFU or postbiotic content matched to the doses used in the published clinical evidence — not to whatever the bulk supplier had on hand.
Measurable host endpoint
Each programme defines a host-level endpoint — symptom score, biomarker, microbiome shift — so the effect is something a clinician can actually track.
Where we are,
and where we're going.
Medalta is currently distributed in 14 markets across Europe, the GCC and South-East Asia. Twenty-two more are open for partner discussions in 2026.
Don't see your market?
If your country isn't listed, write to us anyway. We open new territories every quarter and we'd rather hear from you than miss the conversation.
Choose the strain,
not just the genus.
Verified practitioners get the full dossier library, professional pricing, the medical hotline and a chairside sample programme. Verification typically takes one working day.